Meet the Researcher: Nicola McCarthy, Milner Therapeutics Institute
Drug Discovery World
JULY 3, 2024
NM: So, what we’re interested in the Milner is basically partnering between pharma and academia. We have a big consortium agreement that, at the moment, involves 14 pharma companies. NM: I think probably it’s big data. I think those models are the real areas that we need to solve at the moment.
59 
Let's personalize your content